参考文献
1: Esposito S, Principi N. Oseltamivir for influenza infection in children: risks and benefits. Expert Rev Respir Med. 2016;10(1):79-87. doi: 10.1586/17476348.2016.1126182. Epub 2015 Dec 19. Review. PubMed PMID: 26616633.
2: Beigi RH, Pillai VC, Venkataramanan R, Caritis SN. Oseltamivir for the treatment of H1N1 influenza during pregnancy. Clin Pharmacol Ther. 2015 Oct;98(4):403-5. doi: 10.1002/cpt.179. Epub 2015 Jul 22. Review. PubMed PMID: 26108913.
3: Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015 May 2;385(9979):1729-37. doi: 10.1016/S0140-6736(14)62449-1. Epub 2015 Jan 30. Review. Erratum in: Lancet. 2015 May 2;385(9979):1728. Lancet. 2015 May 2;385(9979):1728. PubMed PMID: 25640810.
4: Wagner J, Abdel-Rahman SM. Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review. Pediatrics. 2015 May;135(5):e1333-6. doi: 10.1542/peds.2014-2578. Review. PubMed PMID: 25917992.
5: McQuade B, Blair M. Influenza treatment with oseltamivir outside of labeled recommendations. Am J Health Syst Pharm. 2015 Jan 15;72(2):112-6. doi: 10.2146/ajhp140390. Review. PubMed PMID: 25550133.
6: In brief: concerns about oseltamivir (Tamiflu). Med Lett Drugs Ther. 2015 Jan 19;57(1460):14. Epub 2015 Jan 19. Review. PubMed PMID: 25536909.
7: Beigi RH, Venkataramanan R, Caritis SN. Oseltamivir for influenza in pregnancy. Semin Perinatol. 2014 Dec;38(8):503-7. doi: 10.1053/j.semperi.2014.08.015. Epub 2014 Oct 1. Review. PubMed PMID: 25281358.
8: Wollenhaupt M, Chandrasekaran A, Tomianovic D. The safety of oseltamivir in pregnancy: an updated review of post-marketing data. Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1035-42. doi: 10.1002/pds.3673. Epub 2014 Jul 4. Review. PubMed PMID: 24995623.
9: Flannery AH, Thompson Bastin ML. Oseltamivir Dosing in Critically Ill Patients With Severe Influenza. Ann Pharmacother. 2014 May 9;48(8):1011-1018. [Epub ahead of print] Review. PubMed PMID: 24816209.
10: Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014 Apr 9;348:g2545. doi: 10.1136/bmj.g2545. Review. PubMed PMID: 24811411; PubMed Central PMCID: PMC3981975.
11: Freemantle N, Shallcross LJ, Kyte D, Rader T, Calvert MJ. Oseltamivir: the real world data. BMJ. 2014 Apr 9;348:g2371. doi: 10.1136/bmj.g2371. Review. PubMed PMID: 24811409.
12: Zhao P, Yang HZ, Lv HY, Wei ZM. Efficacy of Lianhuaqingwen capsule compared with oseltamivir for influenza A virus infection: a meta-analysis of randomized, controlled trials. Altern Ther Health Med. 2014 Mar-Apr;20(2):25-30. Review. PubMed PMID: 24657957.
13: Kosasih H, Bratasena A, Pangesti K, Laras K, Samaan G. Managing seasonal influenza: oseltamivir treatment policy in indonesia? Acta Med Indones. 2014 Jan;46(1):58-65. Review. PubMed PMID: 24760811.
14: Mortada M, Neuenschwander P, Tekko SS. Influenza and oseltamivir phosphate (Tamiflu) in infants: what you need to know. Pediatr Nurs. 2014 Jan-Feb;40(1):16-20. Review. PubMed PMID: 24757915.
15: Ebell MH, Call M, Shinholser J. Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract. 2013 Apr;30(2):125-33. doi: 10.1093/fampra/cms059. Epub 2012 Sep 20. Review. PubMed PMID: 22997224.
16: Tashani M, Rashid H, Ridda I, Heron L, Memish ZA, Haworth E, Booy R. Oseltamivir for control of influenza at mass gatherings. Infect Disord Drug Targets. 2013 Feb;13(1):46-52. Review. PubMed PMID: 23675926.
17: Standing JF, Tsolia M, Lutsar I. Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and children. Infect Disord Drug Targets. 2013 Feb;13(1):6-14. Review. PubMed PMID: 23675922.
18: Yin JK, Heron L, Salkeld G, Rashid H, Booy R. Oseltamivir use in adolescents and adults: clinical and economic considerations. Infect Disord Drug Targets. 2013 Feb;13(1):53-8. Review. PubMed PMID: 23675927.
19: Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic. Infect Disord Drug Targets. 2013 Feb;13(1):34-45. Review. PubMed PMID: 23675925.
20: Karadag-Oncel E, Ceyhan M. Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology. Infect Disord Drug Targets. 2013 Feb;13(1):15-24. Review. PubMed PMID: 23675923.
